Nebula Research & Development LLC Keros Therapeutics, Inc. Transaction History
Nebula Research & Development LLC
- $852 Billion
- Q4 2024
A detailed history of Nebula Research & Development LLC transactions in Keros Therapeutics, Inc. stock. As of the latest transaction made, Nebula Research & Development LLC holds 71,710 shares of KROS stock, worth $740,047. This represents 0.13% of its overall portfolio holdings.
Number of Shares
71,710
Previous 13,439
433.6%
Holding current value
$740,047
Previous $780 Million
45.46%
% of portfolio
0.13%
Previous 0.09%
Shares
3 transactions
Others Institutions Holding KROS
# of Institutions
172Shares Held
29.9MCall Options Held
341KPut Options Held
102K-
Black Rock Inc. New York, NY2.51MShares$25.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.96MShares$20.2 Million0.0% of portfolio
-
Braidwell LP Stamford, CT1.89MShares$19.6 Million1.68% of portfolio
-
Darwin Global Management, Ltd. St. Helier, Y91.69MShares$17.4 Million2.53% of portfolio
-
State Street Corp Boston, MA1.2MShares$12.4 Million0.0% of portfolio
About Keros Therapeutics, Inc.
- Ticker KROS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,757,000
- Market Cap $266M
- Description
- Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. The company's lead protein therapeutic product candidate is KER-050, which is being developed ...